Search
Valziflocept
go.drugbank.com/drugs/DB17728InvestigationalSynonyms: Recombinant human soluble fc-gamma receptor iib, Fc.gamma.riib receptor (human soluble extracellular fragment)Tividenofusp alfa
go.drugbank.com/drugs/DB17628ApprovedInvestigationalDeveloped by Denali Therapeutics, tividenofusp alfa received FDA approval on March 25, 2026, under the accelerated approval pathway [L56097, L56099]. … Tividenofusp alfa is a recombinant human IDS fused to a monoclonal antibody that targets the human insulin receptor (HIR), utilizing receptor-mediated transcytosis to gain access to the central nervous
Synonyms: ENZYME TRANSPORT VEHICLE SPECIFIC FOR THE TRANSFERRIN RECEPTOR FUSED TO IDURONATE 2-SULFATASE, -bis(disulfide) with immunoglobulin Fcab anti-(human type 1 transferrin receptor) (synthetic huSipavibart
go.drugbank.com/drugs/DB21908ApprovedInvestigational[A274098] It works by binding to the SARS-CoV-2 spike protein receptor binding domain (RBD), neutralize the virus and preventing its entry into the host cell.
Synonyms: Immunoglobulin G1-lambda, anti-[Homo sapiens severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], Homo sapiens monoclonal antibody, Immunoglobulin G1 [242-phenylalanine,243-glutamic acid,260-tyrosine,262-threonine,264-glutamic acid,339-serine], anti-(severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor-bindingB7-H3-specific chimeric antigen receptor T cells
go.drugbank.com/drugs/DB18567ExperimentalSynonyms: B7-H3-specific chimeric antigen receptor T cells, Autologous chimeric antigen receptor (CAR) T cells targeting B7-H3PA3-17
go.drugbank.com/drugs/DB18569InvestigationalPA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.
Synonyms: Chimeric Antigen Receptor T Cells targeting CD7CLL1-CD33 compound chimeric antigen receptor T cells
go.drugbank.com/drugs/DB18568InvestigationalSynonyms: CLL1-CD33 compound chimeric antigen receptor T cells, Chimeric Antigen Receptor immunotherapy directed against CLL-1 and CD33Olanzapine
go.drugbank.com/drugs/DB00334ApprovedInvestigationalOlanzapine is a thienobenzodiazepine derivative and an atypical or second-generation antipsychotic agent. Its chemical structure contains a thieno[2,3-b][1,5]benzodiazepine core, and has a methyl group attached to the piperazine ring. Th...
Categories: Adrenergic alpha-1 Receptor Antagonists, Serotonin Receptor AntagonistsProducts: OLANZAPIN-NEURAX 5MG FTA, OLANZAPIN-NEURAX 10MG FTANystatin
go.drugbank.com/drugs/DB00646ApprovedInvestigationalVet approvedNystatin is a polyene antifungal drug that has broad-spectrum fungicidal and fungistatic activity against a number of yeasts and fungi, most notably Candida species. It is one of the most effective antifungal agents synthesized by bacter...
Products: NYSTATIN HOLSTEN FTAOriCar-017
go.drugbank.com/drugs/DB17280InvestigationalSynonyms: chimeric antigen receptor (CAR)-T cell therapy targeting G protein-coupled receptor class-C group-5 member-D (GPRC5D)Donepezil
go.drugbank.com/drugs/DB00843ApprovedInvestigational[L7916,L7937] A donepezil transdermal delivery system, Adlarity, was approved by the FDA in March 2022 for the treatment of Alzheimer's dementia. … Donepezil was first approved by the FDA in 1996, and its extended-release form was approved in combination with [Memantine] in 2014 to manage moderate and severe forms of Alzheimer's dementia.
Products: ARICEPT 10 MG FTA, DONEPEZIL HCL ABZ 5MG FTA